The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
 
Wolfgang Wick
Consulting or Advisory Role - Apogenix (Inst); Lilly (Inst); MSD Oncology; Mundipharma (I); Roche Pharma AG
Research Funding - Apogenix (Inst); Boehringer Ingelheim (Inst); MSD (Inst); Roche TCRC (Inst)
 
Patrick Roth
No Relationships to Disclose
 
Benedikt Wiestler
No Relationships to Disclose
 
Christian Hartmann
No Relationships to Disclose
 
Peter Hau
No Relationships to Disclose
 
Makoto Nakamura
No Relationships to Disclose
 
Florian Stockhammer
No Relationships to Disclose
 
Michael Sabel
No Relationships to Disclose
 
Susanne Koeppen
No Relationships to Disclose
 
Ralf Ketter
No Relationships to Disclose
 
Peter Vajkoczy
No Relationships to Disclose
 
Ilker Eyupoglus
No Relationships to Disclose
 
Stephen Kaendler
No Relationships to Disclose
 
Rolf Kalff
No Relationships to Disclose
 
Norbert Galldiks
No Relationships to Disclose
 
Friederike Schmidt-Graf
No Relationships to Disclose
 
Andreas von Deimling
No Relationships to Disclose
 
Michael Platten
No Relationships to Disclose
 
Guido Reifenberger
Honoraria - Merck Serono
 
Michael Weller
Honoraria - Merck Serono; MSD Oncology; Roche Pharma AG
Consulting or Advisory Role - Celldex; Merck Serono; MSD Oncology; Roche Pharma AG
Research Funding - Merck Serono (Inst); MSD Oncology (Inst)